Funding for this research was provided by:
The Jikei University Research Fund for Graduate Students
JSPS KAKENHI (20K23238)
Received: 25 April 2022
Accepted: 14 September 2022
First Online: 3 October 2022
: We conducted this study in accordance with the Declaration of Helsinki and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. This study was approved by the Ethics Committee of The Jikei University School of Medicine (the acceptance number: 33–124 ). The principal investigator fully informed the patients regarding the content of our previous study, and patients who agreed to participate provided their written consent. Additionally, information regarding the conduct of the present study was disclosed to all potential participants. They were also provided the opportunity to decline participation in the study.
: Not applicable.
: MM’s son-in-law has worked at IQVIA Services Japan K.K., which is a contract research organization and a contract sales organization. MM’s son-in-law works at SYNEOS HEALTH CLINICAL K.K., which is a contract research organization and a contract sales organization. The other authors declare that they have no competing interests.